Endo Pharmaceuticals Revenue and Competitors

Location

$295M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Endo Pharmaceuticals's estimated annual revenue is currently $145.8M per year.(i)
  • Endo Pharmaceuticals's estimated revenue per employee is $281,400
  • Endo Pharmaceuticals's total funding is $295M.

Employee Data

  • Endo Pharmaceuticals has 518 Employees.(i)
  • Endo Pharmaceuticals grew their employee count by 7% last year.

Endo Pharmaceuticals's People

NameTitleEmail/Phone
1
VP Global ERP Systems & TechnologyReveal Email/Phone
2
Executive Director, Customer Service and OperationsReveal Email/Phone
3
Director, QA Generic ProductsReveal Email/Phone
4
Aesthetics Consumer Marketing DirectorReveal Email/Phone
5
Drug Safety ManagerReveal Email/Phone
6
Senior Manager, Quality OperationsReveal Email/Phone
7
Lab Manager (R&D)Reveal Email/Phone
8
Pharmacovigilance Senior Triage ManagerReveal Email/Phone
9
Supply Chain ManagerReveal Email/Phone
10
Information Technology Security ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Endo Pharmaceuticals?

Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Endo Pharmaceuticals' specialty portfolio includes products for urology, men's health, orthopedics and endocrinology. Endo Pharmaceuticals is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.

keywords:N/A

$295M

Total Funding

518

Number of Employees

$145.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Endo Pharmaceuticals News

2022-04-20 - 1 drug company settles ahead of San Francisco opioid trial

Drugmaker Endo Pharmaceuticals has agreed to pay the city of San Francisco $10 million over its role in selling prescription opioids in the...

2022-04-19 - Endo Reaches $10M Deal With SF Ahead Of Opioid Trial

Law360 (April 20, 2022, 11:01 PM EDT) -- Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San...

2022-04-19 - Endo Pharma, San Francisco reach $10M settlement over opioid claims, says AP

Endo Pharmaceuticals (NASDAQ:ENDP) has agreed to pay the city of San Francisco $10M over its role in the sale of prescription opioids in the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M538-6%N/A
#2
$182.6M5418%N/A
#3
$183.3M5436%N/A
#4
$120M5978%N/A
#5
$96.9M6468%N/A